Back to Search
Start Over
Oxford BioMedica in #16.4m deal
- Source :
- Chemist & Druggist. Jan 27, 2001, 33
- Publication Year :
- 2001
-
Abstract
- Oxford BioMedica (OB) could earn up to $24 million (#16.4 million) after selling the rights of an anti-cancer therapy to American Home Products. Under the agreement Wyeth-Ayerst Laboratories, a subsidiary [...]
- Subjects :
- Wyeth -- Mergers, acquisitions and divestments
Oxford BioMedica PLC -- Mergers, acquisitions and divestments
American Home Products Corp. Wyeth-Ayerst Laboratories Div. -- Mergers, acquisitions and divestments
Pharmaceutical industry -- Mergers, acquisitions and divestments
Chemicals, plastics and rubber industries
Pharmaceuticals and cosmetics industries
Subjects
Details
- ISSN :
- 00093033
- Database :
- Gale General OneFile
- Journal :
- Chemist & Druggist
- Publication Type :
- Periodical
- Accession number :
- edsgcl.69841204